<DOC>
	<DOCNO>NCT01453374</DOCNO>
	<brief_summary>This phase 4 study evaluate feasibility initiate subject VIVITROL prison continue VIVITROL upon release community .</brief_summary>
	<brief_title>A Study VIVITROL Prevention Re-arrest Re-incarceration</brief_title>
	<detailed_description>This open-label study pre-post design . Pre-release opioid-dependent subject 4 Baltimore , MD area prison ( three men one woman ) receive 1 injection VIVITROL prior release prison offer 6 monthly injection VIVITROL 6 month post release . Subjects complete follow-up visit 1 2 month last VIVITROL injection . Subjects assess 10 time point , adherence VIVITROL , prison community , assess .</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Not currently addict opioids , diagnosis preincarceration opioid dependence Inmate Metropolitan Transition Center ( Baltimore , MD ) , Maryland Correctional Institute Women ( Jessup , MD ) , Baltimore PreRelease Unit ( Baltimore , MD ) , Jessup PreRelease Unit ( Jessup , MD ) eligible release within 30 day screen Expressing goal opiatefree treatment upon release Currently opioid free Planning live Baltimore , MD area least 8 month follow prison release Pregnancy and/or breastfeed Clinically significant active medical condition Active hepatitis Past present history AIDSindicator disease subject infect HIV Any untreated unstable psychiatric disorder ( eg , bipolar mania ) Recent suicidal ideation Current chronic pain diagnosis opioids prescribe Positive drug test opioids History drug overdose within past 3 year require inpatient hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>VIVITROL</keyword>
	<keyword>criminal justice</keyword>
</DOC>